Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03542409 · ClinicalTrials.gov registry record · NA
Safety and Feasibility of Preoperative and Intraoperative Image-Guided Resection of Gliomas
A NA study of Brain Tumor Adult, sponsored by University of Utah.
- Active
- Registry status
- NA
- Development phase
- 53
- Enrollment target
- 1
- Study location
NCT03542409: Active NA study of Brain Tumor Adult, sponsored by University of Utah.
NCT03542409 is a NA study of Brain Tumor Adult that is active but no longer recruiting, run by University of Utah. The registered enrollment target is 53 participants, below the 71-participant average among 6 other Brain Tumor Adult trials with a reported enrollment target (25% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03542409, a NA study of Brain Tumor Adult, is active but no longer recruiting, sponsored by University of Utah.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the use of specialized magnetic resonance imaging (MRI) techniques including magnetic resonance (MR) perfusion and 2-hydroxyglutarate (2HG) spectroscopy in the surgical treatment of gliomas. Cohort 1 participants will undergo an MR perfusion scan or 2-HG spectroscopy prior to surgery and intra-operatively. Cohort 2 participants will only undergo standard of care imaging and tumor acquisition. Participant participation will end at the completion of surgery and will be transitioned to standard of care follow-up.
Primary Outcome
This is a feasibility study to see whether advanced imaging modalities can be used intraoperatively so the primary outcome is a yes/no regarding completion of imaging.
Conditions Studied
Interventions
- OTHER MR Perfusion Scan
- OTHER 2HG Spectroscopy Scan
- OTHER Standard of Care Intraoperative MRI
Study Locations (1)
Utah
- Huntsman Cancer Institute - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2017-02-15 |
| Est. Completion | 2026-07 |
| Phase | NA |
What the registry record for NCT03542409 still lists
NCT03542409 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 71-participant average among 6 other Brain Tumor Adult trials with a reported enrollment target (25% lower).
The record links to 1 condition, with Brain Tumor Adult appearing as the primary indexed condition, and to 3 interventions - of which MR Perfusion Scan is the first listed.
NCT03542409 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT03542409 about?
NCT03542409 is a clinical study titled "Safety and Feasibility of Preoperative and Intraoperative Image-Guided Resection of Gliomas". This study evaluates the use of specialized magnetic resonance imaging (MRI) techniques including magnetic resonance (MR) perfusion and 2-hydroxyglutarate (2HG) spectroscopy in the surgical treatment of gliomas. Cohort 1 participants will undergo an MR perfusion scan or 2-HG spectroscopy prior to s...
What is the current status of trial NCT03542409?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 53 participants. The study started on 2017-02-15. Estimated completion is 2026-07.
What conditions does trial NCT03542409 study?
This clinical trial studies the following conditions: Brain Tumor Adult.
What interventions are being tested in trial NCT03542409?
The interventions under investigation include: MR Perfusion Scan (OTHER), 2HG Spectroscopy Scan (OTHER), Standard of Care Intraoperative MRI (OTHER).
Who is sponsoring clinical trial NCT03542409?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03542409 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Tumor Adult
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
-
Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI)
RECRUITING
-
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
RECRUITING · Phase 1
-
Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures
RECRUITING · Phase 4
-
A Study of Cognitive Changes in Patients Receiving Brain Radiation
ACTIVE NOT RECRUITING
-
Novel Gamma-Delta (γδ)T Cell Therapy for Treatment of Patients With Newly Diagnosed Glioblastoma
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI